HEMISPHERE ENERGY CORP (HME.CA) Stock Fundamental Analysis
Canada • TSX Venture Exchange • TSX-V:HME • CA4236301020
2.11 CAD
-0.01 (-0.47%)
Last: Feb 10, 2026, 07:00 PM
Taking everything into account, HME scores 7 out of 10 in our fundamental rating. HME was compared to 212 industry peers in the Oil, Gas & Consumable Fuels industry. HME has outstanding health and profitabily ratings, belonging to the best of the industry. This is a solid base for any company. HME is valued quite cheap, but it does not seem to be growing. These ratings would make HME suitable for value investing!
1. Profitability
1.1 Basic Checks
- In the past year HME was profitable.
- In the past year HME had a positive cash flow from operations.
- HME had positive earnings in 4 of the past 5 years.
- Each year in the past 5 years HME had a positive operating cash flow.
1.2 Ratios
- HME's Return On Assets of 24.66% is amongst the best of the industry. HME outperforms 97.64% of its industry peers.
- Looking at the Return On Equity, with a value of 38.33%, HME belongs to the top of the industry, outperforming 99.06% of the companies in the same industry.
- HME has a better Return On Invested Capital (31.98%) than 100.00% of its industry peers.
- Measured over the past 3 years, the Average Return On Invested Capital for HME is significantly above the industry average of 6.50%.
- The 3 year average ROIC (38.31%) for HME is well above the current ROIC(31.98%). The reason for the recent decline needs to be investigated.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 24.66% | ||
| ROE | 38.33% | ||
| ROIC | 31.98% |
ROA(3y)27.91%
ROA(5y)18.35%
ROE(3y)41.42%
ROE(5y)28.93%
ROIC(3y)38.31%
ROIC(5y)29.36%
1.3 Margins
- HME's Profit Margin of 30.81% is amongst the best of the industry. HME outperforms 95.28% of its industry peers.
- In the last couple of years the Profit Margin of HME has grown nicely.
- HME has a Operating Margin of 42.73%. This is amongst the best in the industry. HME outperforms 92.92% of its industry peers.
- HME's Operating Margin has improved in the last couple of years.
- HME has a Gross Margin of 60.82%. This is in the better half of the industry: HME outperforms 79.25% of its industry peers.
- HME's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 42.73% | ||
| PM (TTM) | 30.81% | ||
| GM | 60.82% |
OM growth 3Y2.1%
OM growth 5Y4.69%
PM growth 3Y34.16%
PM growth 5Y45.92%
GM growth 3Y-1.38%
GM growth 5Y-1.19%
2. Health
2.1 Basic Checks
- With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), HME is creating value.
- Compared to 1 year ago, HME has less shares outstanding
- HME has more shares outstanding than it did 5 years ago.
- Compared to 1 year ago, HME has an improved debt to assets ratio.
2.2 Solvency
- An Altman-Z score of 4.98 indicates that HME is not in any danger for bankruptcy at the moment.
- With an excellent Altman-Z score value of 4.98, HME belongs to the best of the industry, outperforming 84.43% of the companies in the same industry.
- The Debt to FCF ratio of HME is 0.07, which is an excellent value as it means it would take HME, only 0.07 years of fcf income to pay off all of its debts.
- HME has a Debt to FCF ratio of 0.07. This is amongst the best in the industry. HME outperforms 96.23% of its industry peers.
- A Debt/Equity ratio of 0.03 indicates that HME is not too dependend on debt financing.
- HME has a better Debt to Equity ratio (0.03) than 76.42% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.03 | ||
| Debt/FCF | 0.07 | ||
| Altman-Z | 4.98 |
ROIC/WACC3.96
WACC8.07%
2.3 Liquidity
- HME has a Current Ratio of 1.41. This is a normal value and indicates that HME is financially healthy and should not expect problems in meeting its short term obligations.
- HME has a better Current ratio (1.41) than 72.64% of its industry peers.
- HME has a Quick Ratio of 1.41. This is a normal value and indicates that HME is financially healthy and should not expect problems in meeting its short term obligations.
- Looking at the Quick ratio, with a value of 1.41, HME is in the better half of the industry, outperforming 74.53% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.41 | ||
| Quick Ratio | 1.41 |
3. Growth
3.1 Past
- The earnings per share for HME have decreased by -9.09% in the last year.
- HME shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 80.04% yearly.
- Looking at the last year, HME shows a decrease in Revenue. The Revenue has decreased by -0.77% in the last year.
- HME shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 25.97% yearly.
EPS 1Y (TTM)-9.09%
EPS 3Y72.84%
EPS 5Y80.04%
EPS Q2Q%-22.22%
Revenue 1Y (TTM)-0.77%
Revenue growth 3Y32.32%
Revenue growth 5Y25.97%
Sales Q2Q%-13.24%
3.2 Future
- HME is expected to show a very negative growth in Earnings Per Share. In the coming years, the EPS will decrease by -15.87% yearly.
- HME is expected to show a decrease in Revenue. In the coming years, the Revenue will decrease by -7.01% yearly.
EPS Next Y-14.17%
EPS Next 2Y-9.92%
EPS Next 3Y-9.18%
EPS Next 5Y-15.87%
Revenue Next Year-5.82%
Revenue Next 2Y-3.77%
Revenue Next 3Y-4.28%
Revenue Next 5Y-7.01%
3.3 Evolution
- The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
- The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
- With a Price/Earnings ratio of 7.03, the valuation of HME can be described as very cheap.
- HME's Price/Earnings ratio is rather cheap when compared to the industry. HME is cheaper than 91.04% of the companies in the same industry.
- HME's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 28.03.
- Based on the Price/Forward Earnings ratio of 7.88, the valuation of HME can be described as very cheap.
- Based on the Price/Forward Earnings ratio, HME is valued cheaper than 82.08% of the companies in the same industry.
- HME's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 27.97.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 7.03 | ||
| Fwd PE | 7.88 |
4.2 Price Multiples
- Based on the Enterprise Value to EBITDA ratio, HME is valued cheaply inside the industry as 92.45% of the companies are valued more expensively.
- 97.64% of the companies in the same industry are more expensive than HME, based on the Price/Free Cash Flow ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 4.57 | ||
| EV/EBITDA | 3.32 |
4.3 Compensation for Growth
- HME has an outstanding profitability rating, which may justify a higher PE ratio.
- A cheap valuation may be justified as HME's earnings are expected to decrease with -9.18% in the coming years.
PEG (NY)N/A
PEG (5Y)0.09
EPS Next 2Y-9.92%
EPS Next 3Y-9.18%
5. Dividend
5.1 Amount
- With a Yearly Dividend Yield of 4.81%, HME is a good candidate for dividend investing.
- Compared to an average industry Dividend Yield of 3.13, HME pays a bit more dividend than its industry peers.
- HME's Dividend Yield is rather good when compared to the S&P500 average which is at 1.80.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 4.81% |
5.2 History
- HME has been paying a dividend for over 5 years, so it has already some track record.
- HME has decreased its dividend in the last 3 years.
Dividend Growth(5Y)N/A
Div Incr Years2
Div Non Decr Years2
5.3 Sustainability
- HME pays out 60.59% of its income as dividend. This is not a sustainable payout ratio.
DP60.59%
EPS Next 2Y-9.92%
EPS Next 3Y-9.18%
TSX-V:HME (2/10/2026, 7:00:00 PM)
2.11
-0.01 (-0.47%)
Chartmill FA Rating
GICS SectorEnergy
GICS IndustryGroupEnergy
GICS IndustryOil, Gas & Consumable Fuels
Earnings (Last)11-25 2025-11-25/bmo
Earnings (Next)04-15 2026-04-15/amc
Inst Owners0.71%
Inst Owner ChangeN/A
Ins Owners16.81%
Ins Owner ChangeN/A
Market Cap199.67M
Revenue(TTM)98.24M
Net Income(TTM)30.27M
Analysts84
Price Target2.6 (23.22%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 4.81% |
Yearly Dividend0.16
Dividend Growth(5Y)N/A
DP60.59%
Div Incr Years2
Div Non Decr Years2
Ex-Date02-12 2026-02-12 (0.025)
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-2.91%
Min EPS beat(2)-2.91%
Max EPS beat(2)-2.91%
EPS beat(4)1
Avg EPS beat(4)-1.48%
Min EPS beat(4)-2.91%
Max EPS beat(4)2.8%
EPS beat(8)3
Avg EPS beat(8)-2.87%
EPS beat(12)5
Avg EPS beat(12)1.35%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)2.89%
Min Revenue beat(2)-0.21%
Max Revenue beat(2)5.99%
Revenue beat(4)3
Avg Revenue beat(4)2.9%
Min Revenue beat(4)-0.21%
Max Revenue beat(4)5.99%
Revenue beat(8)5
Avg Revenue beat(8)0.35%
Revenue beat(12)7
Avg Revenue beat(12)-0.67%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)5.15%
PT rev (3m)12.09%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-18.18%
EPS NY rev (1m)0%
EPS NY rev (3m)-3.51%
Revenue NQ rev (1m)1.18%
Revenue NQ rev (3m)-10.01%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-1.77%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 7.03 | ||
| Fwd PE | 7.88 | ||
| P/S | 2.03 | ||
| P/FCF | 4.57 | ||
| P/OCF | 3.59 | ||
| P/B | 2.53 | ||
| P/tB | 2.53 | ||
| EV/EBITDA | 3.32 |
EPS(TTM)0.3
EY14.22%
EPS(NY)0.27
Fwd EY12.69%
FCF(TTM)0.46
FCFY21.88%
OCF(TTM)0.59
OCFY27.84%
SpS1.04
BVpS0.83
TBVpS0.83
PEG (NY)N/A
PEG (5Y)0.09
Graham Number2.37
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 24.66% | ||
| ROE | 38.33% | ||
| ROCE | 42.48% | ||
| ROIC | 31.98% | ||
| ROICexc | 43.34% | ||
| ROICexgc | 43.34% | ||
| OM | 42.73% | ||
| PM (TTM) | 30.81% | ||
| GM | 60.82% | ||
| FCFM | 44.47% |
ROA(3y)27.91%
ROA(5y)18.35%
ROE(3y)41.42%
ROE(5y)28.93%
ROIC(3y)38.31%
ROIC(5y)29.36%
ROICexc(3y)41.04%
ROICexc(5y)31.02%
ROICexgc(3y)41.04%
ROICexgc(5y)31.02%
ROCE(3y)50.88%
ROCE(5y)39%
ROICexgc growth 3Y12.92%
ROICexgc growth 5Y20.01%
ROICexc growth 3Y12.92%
ROICexc growth 5Y20.01%
OM growth 3Y2.1%
OM growth 5Y4.69%
PM growth 3Y34.16%
PM growth 5Y45.92%
GM growth 3Y-1.38%
GM growth 5Y-1.19%
F-Score6
Asset Turnover0.8
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.03 | ||
| Debt/FCF | 0.07 | ||
| Debt/EBITDA | 0.04 | ||
| Cap/Depr | 105.19% | ||
| Cap/Sales | 12.1% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 104.31% | ||
| Profit Quality | 144.34% | ||
| Current Ratio | 1.41 | ||
| Quick Ratio | 1.41 | ||
| Altman-Z | 4.98 |
F-Score6
WACC8.07%
ROIC/WACC3.96
Cap/Depr(3y)210.69%
Cap/Depr(5y)187.35%
Cap/Sales(3y)20.24%
Cap/Sales(5y)19.51%
Profit Quality(3y)104.52%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-9.09%
EPS 3Y72.84%
EPS 5Y80.04%
EPS Q2Q%-22.22%
EPS Next Y-14.17%
EPS Next 2Y-9.92%
EPS Next 3Y-9.18%
EPS Next 5Y-15.87%
Revenue 1Y (TTM)-0.77%
Revenue growth 3Y32.32%
Revenue growth 5Y25.97%
Sales Q2Q%-13.24%
Revenue Next Year-5.82%
Revenue Next 2Y-3.77%
Revenue Next 3Y-4.28%
Revenue Next 5Y-7.01%
EBIT growth 1Y-3.75%
EBIT growth 3Y35.09%
EBIT growth 5Y31.88%
EBIT Next Year34.08%
EBIT Next 3Y-0.98%
EBIT Next 5Y-5.77%
FCF growth 1Y130.83%
FCF growth 3Y57.01%
FCF growth 5YN/A
OCF growth 1Y39.86%
OCF growth 3Y36.33%
OCF growth 5Y34.82%
HEMISPHERE ENERGY CORP / HME.CA FAQ
What is the ChartMill fundamental rating of HEMISPHERE ENERGY CORP (HME.CA) stock?
ChartMill assigns a fundamental rating of 7 / 10 to HME.CA.
What is the valuation status for HME stock?
ChartMill assigns a valuation rating of 8 / 10 to HEMISPHERE ENERGY CORP (HME.CA). This can be considered as Undervalued.
Can you provide the profitability details for HEMISPHERE ENERGY CORP?
HEMISPHERE ENERGY CORP (HME.CA) has a profitability rating of 9 / 10.
What is the financial health of HEMISPHERE ENERGY CORP (HME.CA) stock?
The financial health rating of HEMISPHERE ENERGY CORP (HME.CA) is 8 / 10.
Can you provide the dividend sustainability for HME stock?
The dividend rating of HEMISPHERE ENERGY CORP (HME.CA) is 5 / 10 and the dividend payout ratio is 60.59%.